References
- Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980;1:55–9
- Bevilacqua O, Parmigiani S, on behalf of the OBSERVES group. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophy-laxis and early rescue. J Matem-Fetal Neonatal Med 2003; 14:197–204
- Lefort S, Diniz EMA, Vaz AC. Clinical course of premature infants intubated in the delivery room, submitted or not to porcine-derived lung surfactant therapy within the first hour of life. J Matem-Fetal Neonatal Med 2003;14: 187–96
- Verder H, Robertson B, Greisen O, et al. Surfactant therapy and nasal continuous positive airway pressure for new-borns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 1994;331:1051–5